Epigenetic Mismatches with Mutated Transcribing Genes at Leukemogenic S-Phase Binding/Start Sites – Potential Targets for Therapy with Enzyme Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 2212-3946|7|6|420-429

ISSN： 1574-888X

Source： Current Stem Cell Research & Therapy, Vol.7, Iss.6, 2012-11, pp. : 420-429

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibitors of Apoptosis Proteins (IAPs) as Potential Molecular Targets for Therapy of Hematological Malignancies

By  

Current Molecular Medicine, Vol. 11, Iss. 8, 2011-11 ,pp. : 633-649

Bentham Science Publishers

Access to resources Recommend Favorite

ATP-binding cassette transporters and calcineurin inhibitors: potential clinical implications

By van Gelder T.   Klupp J.   Sawamoto T.   Christians U.   Morris R.E.  

Transplantation Proceedings, Vol. 33, Iss. 3, 2001-05 ,pp. : 2420-2421

Elsevier

Access to resources Recommend Favorite

Epigenomics and epigenetic therapy of cancer

By Brown R.   Strathdee G.  

Trends in Molecular Medicine, Vol. 8, Iss. 4, 2002-04 ,pp. : 43-48

Elsevier

Access to resources Recommend Favorite

Intercellular Adhesion Molecule Inhibitors as Potential Therapy for Refractory Uveitic Macular Edema

By Wang Jianmin   Ibrahim Mohamed   Turkcuoglu Peykan   Hatef Elham   Khwaja Afsheen   Channa Roomasa   Do Diana V.   Nguyen Quan Dong  

Ocular Immunology and Inflammation, Vol. 18, Iss. 5, 2010-10 ,pp. : 395-398

Informa Healthcare

Access to resources Recommend Favorite

Epigenetic therapy in MDS and acute AML: focus on decitabine

By Lübbert M.   Wijermans P.  

Annals of Hematology, Vol. 84, Iss. 1, 2005-12 ,pp. : 1-2

Springer Publishing Company

Access to resources Recommend Favorite